KR100658963B1 - 폴리옥시알킬렌 유도체 및 이의 제조방법 - Google Patents
폴리옥시알킬렌 유도체 및 이의 제조방법 Download PDFInfo
- Publication number
- KR100658963B1 KR100658963B1 KR1020020045171A KR20020045171A KR100658963B1 KR 100658963 B1 KR100658963 B1 KR 100658963B1 KR 1020020045171 A KR1020020045171 A KR 1020020045171A KR 20020045171 A KR20020045171 A KR 20020045171A KR 100658963 B1 KR100658963 B1 KR 100658963B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- polyoxyalkylene derivative
- carbon atoms
- polyoxyalkylene
- Prior art date
Links
- 0 CCN*(C)O* Chemical compound CCN*(C)O* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/04—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
- C08G65/22—Cyclic ethers having at least one atom other than carbon and hydrogen outside the ring
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
- C08G65/33331—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group
- C08G65/33337—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group cyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/321—Polymers modified by chemical after-treatment with inorganic compounds
- C08G65/325—Polymers modified by chemical after-treatment with inorganic compounds containing nitrogen
- C08G65/3255—Ammonia
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
- C08G65/332—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
- C08G65/3324—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof cyclic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
- C08G65/33303—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing amino group
Abstract
Description
GPC 순도(%) | 말레이미도 그룹 치환도(%) | 말레산 무수물 함량(중량%) | |
실시예 1 | 97.7 | 95.7 | 0.0011 |
실시예 2 | 94.4 | 93.1 | 0.0018 |
실시예 3 | 92.8 | 92.2 | 0.025 |
비교 실시예 1 | 99.2 | 84.7 | 0.086 |
비교 실시예 2 | 51.6 | 94.3 | 15 |
비교 실시예 3 | 98.4 | 78.0 | - |
24시간 후(%) | 48시간 후(%) | 72시간 후(%) | |
실시예 1 | 81.8 | 63.2 | 47.4 |
비교 실시예 3 | 73.4 | 42.7 | 26.0 |
1개월 후(%) | 2개월 후(%) | 3개월 후(%) | 4개월 후(%) | |
실시예 1 | 98 | 91 | 85 | 78 |
비교 실시예 3 | 80 | 64 | 46 | 31 |
Claims (15)
- 제1항에 있어서, GPC 순도가 90% 이상이고 말레이미도 그룹 치환도가 90% 이상인 폴리옥시알킬렌 유도체.
- 제1항에 있어서, 말레이미도 그룹 치환도 반감기(50% 감소 시간)가 pH 7 및 23℃에서 수행된 가수분해 안정성 시험에서 48시간 이상인 폴리옥시알킬렌 유도체.
- 제2항에 있어서, 말레이미도 그룹 치환도 반감기(50% 감소 시간)가 pH 7 및 23℃에서 수행된 가수분해 안정성 시험에서 48시간 이상인 폴리옥시알킬렌 유도체.
- 제1항에 있어서, Z가 3 내지 8개의 하이드록실 그룹을 갖는 화합물의 잔기이며 a 및 b가 식 3≤a+b≤8을 만족시키는 폴리옥시알킬렌 유도체.
- 제2항에 있어서, Z가 3 내지 8개의 하이드록실 그룹을 갖는 화합물의 잔기이며 a 및 b가 식 3≤a+b≤8을 만족시키는 폴리옥시알킬렌 유도체.
- 제3항에 있어서, Z가 3 내지 8개의 하이드록실 그룹을 갖는 화합물의 잔기이며 a 및 b가 식 3≤a+b≤8을 만족시키는 폴리옥시알킬렌 유도체.
- 제1항에 있어서, 생물학적 물질을 개질시키는데 사용되는 폴리옥시알킬렌 유도체.
- 제1항에 있어서, X가 탄소수 3의 2가 탄화수소 그룹인 폴리옥시알킬렌 유도체.
- 제2항에 있어서, X가 탄소수 3의 2가 탄화수소 그룹인 폴리옥시알킬렌 유도체.
- 제3항에 있어서, X가 탄소수 3의 2가 탄화수소 그룹인 폴리옥시알킬렌 유도체.
- 화학식 3의 아미노-말단화된 폴리옥시알킬렌을 말레산 무수물과 반응시켜 화학식 4의 말레아미드산-말단화된 폴리옥시알킬렌 유도체를 형성시키는 단계,화학식 4의 화합물을 화학식 4의 화합물을 기준으로 하여, 50 내지 500용적/중량%의 유기 용매 속에 용해시키는 단계,화학식 4의 화합물을 기준으로 하여, 300 내지 5000용적/중량%의 에틸 아세테이트와 n-헥산의 혼합물로부터 화학식 4의 화합물을 결정화시키는 단계 및화학식 4의 화합물의 말레아미드산 말단 그룹을 이미드화시키는 단계를 포함하는, 화학식 1의 폴리옥시알킬렌 유도체의 제조방법.화학식 1화학식 3화학식 4상기 화학식에서,Z는 2 내지 8개의 하이드록실 그룹을 갖는 화합물의 잔기를 나타내고,AO는 탄소수 2 내지 18의 옥시알킬렌 그룹을 나타내며,n 및 m은 각각 0 내지 2000의 정수를 나타내며, 단, n 및 m이 둘다 0을 나타내지 않으며,a 및 b는 각각 식 2≤a+b≤8 및 1≤b를 만족시키는 정수를 나타내고,R은 탄소수 1 내지 30의 탄화수소 그룹을 나타내며,X는 탄소수 3 내지 10의 2가 탄화수소 그룹을 나타낸다.
- 화학식 2의 하이드록실-말단화된 폴리옥시알킬렌 유도체를 시안화 이후 수소화시켜 화학식 3의 아미노-말단화된 폴리옥시알킬렌 유도체로 전환시키는 단계,화학식 3의 화합물을 말레산 무수물과 반응시켜 화학식 4의 말레아미드산-말단화된 폴리옥시알킬렌 유도체를 형성하는 단계,화학식 4의 화합물을 화학식 4의 화합물을 기준으로 하여, 50 내지 500용적/중량%의 유기 용매 속에 용해시키는 단계,화학식 4의 화합물을 기준으로 하여, 300 내지 5000용적/중량%의 에틸 아세테이트와 n-헥산의 혼합물로부터 화학식 4의 화합물을 결정화시키는 단계 및화학식 4의 화합물의 말레아미드산 말단 그룹을 이미드화시키는 단계를 포함하는, 화학식 1의 폴리옥시알킬렌 유도체의 제조방법.화학식 1화학식 2화학식 3화학식 4상기 화학식에서,Z는 2 내지 8개의 하이드록실 그룹을 갖는 화합물의 잔기를 나타내고,AO는 탄소수 2 내지 18의 옥시알킬렌 그룹을 나타내며,n 및 m은 각각 0 내지 2000의 정수를 나타내며, 단, n 및 m이 둘다 0을 나타내지 않으며,a 및 b는 각각 식 2≤a+b≤8 및 1≤b를 만족시키는 정수를 나타내고,R은 탄소수 1 내지 30의 탄화수소 그룹을 나타내며,X는 탄소수 3 내지 10의 2가 탄화수소 그룹을 나타낸다.
- 제12항에 있어서, 화학식 4의 말레아미드산-말단화된 폴리옥시알킬렌 유도체의 말레산 무수물 함량이 0.5중량% 이하인, 화학식 1의 폴리옥시알킬렌 유도체의 제조방법.
- 제13항에 있어서, 화학식 4의 말레아미드산-말단화된 폴리옥시알킬렌 유도체의 말레산 무수물 함량이 0.5중량% 이하인, 화학식 1의 폴리옥시알킬렌 유도체의 제조방법.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPJP-P-2001-00232045 | 2001-07-31 | ||
JP2001232045 | 2001-07-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030013256A KR20030013256A (ko) | 2003-02-14 |
KR100658963B1 true KR100658963B1 (ko) | 2006-12-19 |
Family
ID=19064019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020020045171A KR100658963B1 (ko) | 2001-07-31 | 2002-07-31 | 폴리옥시알킬렌 유도체 및 이의 제조방법 |
Country Status (6)
Country | Link |
---|---|
US (1) | US6875841B2 (ko) |
EP (1) | EP1283233B1 (ko) |
JP (1) | JP4123856B2 (ko) |
KR (1) | KR100658963B1 (ko) |
CN (1) | CN1400232A (ko) |
DE (1) | DE60221201T2 (ko) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7543018B2 (en) * | 1996-04-11 | 2009-06-02 | Aol Llc, A Delaware Limited Liability Company | Caching signatures |
US8828373B2 (en) | 2002-11-20 | 2014-09-09 | Nof Corporation | Polyalkylene glycol derivative and modified bio-related substance |
US8003117B2 (en) | 2002-11-20 | 2011-08-23 | Nof Corporation | Polyalkylene glycol derivative and modified bio-related substance |
JP4412461B2 (ja) | 2002-11-20 | 2010-02-10 | 日油株式会社 | 修飾された生体関連物質、その製造方法および中間体 |
ATE399185T1 (de) * | 2002-12-31 | 2008-07-15 | Nektar Therapeutics Al Corp | Maleinsäureamid polymerderivate und ihre biokonjugate |
US7432331B2 (en) | 2002-12-31 | 2008-10-07 | Nektar Therapeutics Al, Corporation | Hydrolytically stable maleimide-terminated polymers |
AU2003300133B2 (en) * | 2002-12-31 | 2008-11-13 | Nektar Therapeutics | Hydrolytically stable maleimide-terminated polymers |
US7482376B2 (en) * | 2003-07-03 | 2009-01-27 | 3-Dimensional Pharmaceuticals, Inc. | Conjugated complement cascade inhibitors |
CA2533702C (en) * | 2003-07-22 | 2012-05-22 | Nektar Therapeutics Al, Corporation | Method for preparing functionalized polymers from polymer alcohols |
US7790835B2 (en) | 2003-12-03 | 2010-09-07 | Nektar Therapeutics | Method of preparing maleimide functionalized polymers |
WO2006088245A1 (ja) * | 2005-02-18 | 2006-08-24 | The University Of Tokushima | ポリオキシアルキレン鎖含有脂質誘導体及び該誘導体を含有する脂質膜構造体 |
WO2006088248A1 (ja) * | 2005-02-18 | 2006-08-24 | Nof Corporation | ポリオキシアルキレン誘導体 |
US8568705B2 (en) | 2005-07-18 | 2013-10-29 | Nektar Therapeutics | Method for preparing branched functionalized polymers using branched polyol cores |
KR101334541B1 (ko) * | 2005-07-19 | 2013-11-28 | 넥타르 테라퓨틱스 | 중합체 말레이미드를 제조하는 방법 |
US7671067B2 (en) * | 2006-02-09 | 2010-03-02 | Enzon Pharmaceuticals, Inc. | Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamtothecin |
US7462627B2 (en) * | 2006-02-09 | 2008-12-09 | Enzon Pharmaceuticals, Inc. | Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers |
KR101513732B1 (ko) | 2006-02-21 | 2015-04-21 | 넥타르 테라퓨틱스 | 분할된 분해가능한 폴리머 및 이로부터 제조된 컨주게이트 |
CN101500614B (zh) * | 2006-02-28 | 2011-08-10 | 雷迪实验室(欧洲)有限公司 | 制备聚乙二醇碳酸酯的方法 |
EP2036952B1 (en) * | 2006-06-30 | 2016-04-20 | Toray Industries, Inc. | Thermoplastic resin composition and molded article thereof |
US7928095B2 (en) * | 2007-02-09 | 2011-04-19 | Enzon Pharmaceuticals, Inc. | Treatment of resistant or refractory cancers with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
JP5428017B2 (ja) * | 2007-03-23 | 2014-02-26 | 国立大学法人 熊本大学 | ワクチン剤 |
KR100771100B1 (ko) * | 2007-07-18 | 2007-10-29 | 아이디비켐(주) | 고순도의 메톡시폴리에틸렌글리콜에틸말레이미드의제조방법 |
JP5159891B2 (ja) * | 2007-10-05 | 2013-03-13 | テレフオンアクチーボラゲット エル エム エリクソン(パブル) | 多重記述符号化のための方法及び装置 |
JPWO2009044918A1 (ja) * | 2007-10-05 | 2011-02-17 | 武田薬品工業株式会社 | ニューロメジンu誘導体 |
KR101001734B1 (ko) | 2008-06-05 | 2010-12-15 | 아이디비켐(주) | 고순도의 메톡시폴리에틸렌글리콜에틸말레이마이드의분석방법 |
TW201010732A (en) * | 2008-08-29 | 2010-03-16 | Enzon Pharmaceuticals Inc | Method of treating RAS associated cancer |
KR20110075029A (ko) * | 2008-10-21 | 2011-07-05 | 엔즌 파마슈티칼스, 인코포레이티드 | 7-에틸-10-하이드록시캄토테신의 다중-암 고분자 컨쥬게이트로 신경모세포종의 치료 |
JP5569787B2 (ja) * | 2009-03-31 | 2014-08-13 | 日油株式会社 | 高分子量ポリエチレングリコール化合物の精製方法 |
US8716435B2 (en) | 2009-03-31 | 2014-05-06 | Nof Corporation | Multibranched polyoxyalkylene compound and producing method thereof |
EP3960215A1 (en) | 2009-12-15 | 2022-03-02 | Incept, LLC | Implants and biodegradable fiducial markers |
AR080446A1 (es) | 2010-03-03 | 2012-04-11 | Boehringer Ingelheim Int | Polipeptidos de union a a-beta (beta amiloide) |
US8816099B2 (en) * | 2010-03-31 | 2014-08-26 | Nof Corporation | Polyfunctional polyoxyalkylene compound, and producing method and intermediate thereof |
US20120135912A1 (en) | 2010-05-10 | 2012-05-31 | Perseid Therapeutics Llc | Polypeptide inhibitors of vla4 |
JP5825507B2 (ja) * | 2010-06-25 | 2015-12-02 | 日油株式会社 | 分岐型ヘテロポリエチレングリコール |
US10040761B2 (en) | 2010-06-25 | 2018-08-07 | Nof Corporation | Branched hetero polyethylene glycol and intermediate |
EP2820046B1 (en) | 2012-02-27 | 2022-06-15 | Ablynx N.V. | Cx3cr1-binding polypeptides |
JP7042053B2 (ja) | 2016-10-07 | 2022-03-25 | 国立大学法人東京工業大学 | 分岐型ヘテロ単分散ポリエチレングリコール、その製造方法、及びその結合体 |
JP6935059B2 (ja) * | 2017-03-30 | 2021-09-15 | 日油株式会社 | カルボキシル基を一つ有するポリエチレングリコールの精製方法 |
JP7204078B2 (ja) * | 2018-03-13 | 2023-01-16 | 日油株式会社 | 主鎖および側鎖に単分散ポリエチレングリコールを有するヘテロ二官能性化合物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0273545A1 (en) * | 1987-01-02 | 1988-07-06 | Texaco Development Corporation | Novel reaction product and ORI-inhibited motor fuel composition |
EP0318162A3 (en) * | 1987-11-25 | 1990-11-07 | Texaco Development Corporation | Novel bismaleimide derivatives |
CA2288429C (en) * | 1991-03-15 | 2006-04-25 | Synergen, Inc. | Pegylation of polypeptides |
JP3562000B2 (ja) * | 1994-12-14 | 2004-09-08 | 日本油脂株式会社 | ポリオキシアルキレンモノアミンの製造方法 |
US5585484A (en) * | 1995-04-19 | 1996-12-17 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Hemoglobin crosslinkers |
JP3092531B2 (ja) * | 1996-11-05 | 2000-09-25 | 日本油脂株式会社 | コハク酸イミジル基置換ポリオキシアルキレン誘導体の製造方法 |
DE69838552T2 (de) | 1997-07-14 | 2008-05-21 | Bolder Biotechnology, Inc., Louisville | Derivate des wachstumshormons und verwandte proteine |
JP2000191700A (ja) | 1998-12-28 | 2000-07-11 | Kyowa Hakko Kogyo Co Ltd | 持続型消化管運動ペプチド |
WO2001062827A2 (en) * | 2000-02-22 | 2001-08-30 | Shearwater Corporation | N-maleimidyl polymer derivatives |
-
2002
- 2002-07-29 JP JP2002220091A patent/JP4123856B2/ja not_active Expired - Fee Related
- 2002-07-30 EP EP02016865A patent/EP1283233B1/en not_active Expired - Lifetime
- 2002-07-30 US US10/206,955 patent/US6875841B2/en not_active Expired - Lifetime
- 2002-07-30 DE DE60221201T patent/DE60221201T2/de not_active Expired - Lifetime
- 2002-07-31 CN CN02127153A patent/CN1400232A/zh active Pending
- 2002-07-31 KR KR1020020045171A patent/KR100658963B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
DE60221201T2 (de) | 2008-02-14 |
JP2003113241A (ja) | 2003-04-18 |
CN1400232A (zh) | 2003-03-05 |
KR20030013256A (ko) | 2003-02-14 |
EP1283233A1 (en) | 2003-02-12 |
DE60221201D1 (de) | 2007-08-30 |
JP4123856B2 (ja) | 2008-07-23 |
US20030065134A1 (en) | 2003-04-03 |
EP1283233B1 (en) | 2007-07-18 |
US6875841B2 (en) | 2005-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100658963B1 (ko) | 폴리옥시알킬렌 유도체 및 이의 제조방법 | |
EP0824126B1 (en) | Preparation of carboxylic acid-containing polyether and biologically active substances derived thereof | |
US5756593A (en) | Method of preparing polyalkyene oxide carboxylic acids | |
EP0973819B1 (en) | Non-antigenic branched polymer conjugates | |
JP5273589B2 (ja) | 生体関連物質、その製造方法およびその中間体 | |
US5643575A (en) | Non-antigenic branched polymer conjugates | |
CA2393638C (en) | Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol) | |
EP1976896B1 (en) | High efficiency method of preparing polyalkylene oxide carboxylic acids | |
US8952125B2 (en) | Polyoxyethylene derivative having plural hydroxyl groups at terminal end thereof | |
US20060073113A1 (en) | Polyalkylene glycol derivative and modified bio-related substance | |
JPWO2006088248A1 (ja) | ポリオキシアルキレン誘導体 | |
EP4036150A1 (en) | Asymmetrically branched degradable polyethylene glycol derivative | |
JPH1087815A (ja) | ポリアルキレンオキシドカルボン酸の改良製造方法 | |
KR20080082994A (ko) | 알파 질소 기를 갖는 활성 폴리머의 제조 방법 | |
JP2000001542A (ja) | カルボキシル基含有ポリオキシアルキレン化合物 | |
MX2008008916A (en) | High efficiency method of preparing polyalkylene oxide carboxylic acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121121 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20131118 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20141120 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20151118 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160701 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170703 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180702 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190701 Year of fee payment: 14 |